Frontiers in Endocrinology (Feb 2024)

Glycemic variability evaluated by HbA1c rather than fasting plasma glucose is associated with adverse cardiovascular events

  • Lijuan Sheng,
  • Guifang Yang,
  • Guifang Yang,
  • Guifang Yang,
  • Xiangping Chai,
  • Xiangping Chai,
  • Xiangping Chai,
  • Yang Zhou,
  • Yang Zhou,
  • Yang Zhou,
  • Xin Sun,
  • Zhenhua Xing,
  • Zhenhua Xing,
  • Zhenhua Xing

DOI
https://doi.org/10.3389/fendo.2024.1323571
Journal volume & issue
Vol. 15

Abstract

Read online

BackgroundAlthough studies have shown that glycemic variability is positively associated with an increased risk of cardiovascular disease, few studies have compared hemoglobin A1c (HbA1c) and fasting plasma glucose (FPG) variability with adverse cardiovascular events in patients with type 2 diabetes mellitus (T2DM).MethodsThis was a post hoc analysis of the Action to Control Cardiovascular Risk in Diabetes (ACCORD) study. Cox proportional hazards models were used to explore the relationship between HbA1c or FPG variability and the incidence of major adverse cardiovascular events (MACEs).ResultsIn total, 9,547 patients with T2DM were enrolled in this study. During the median 4.6 ± 1.5 years follow-up period, 907 patients developed MACEs. The risk of MACEs increased in the HbA1c variability group in each higher quartile of HbA1c variability (P < 0.01). Compared with those in the first quartile of HbA1c variability, patients in the fourth quartile had a hazard ratio of 1.37 (Model 2, 95% confidence interval: 1.13–1.67) for MACEs. Higher FPG variability was not associated with a higher risk of MACEs in patients with T2DM (P for trend=0.28). A U-shaped relationship was observed between HbA1c and FPG variability, and MACEs. Glucose control therapy modified the relationship between HbA1c and MACEs; participants with higher HbA1c variability receiving intensive glucose control were more likely to develop MACEs (P for interaction <0.01).ConclusionIn adults with T2DM, the relationship between glycemic variability evaluated using HbA1c and FPG was U-shaped, and an increase in HbA1c variability rather than FPG variability was significantly associated with MACEs. The relationship between HbA1c variability and MACEs was affected by the glucose control strategy, and a higher HbA1c variability was more strongly associated with MACEs in patients receiving an intensive glucose control strategy.

Keywords